Kurome Therapeutics
Abram Gordon as an Interim Vice President at CCHMC’s Innovation Ventures, an Executive Director at Cincinnati Children’s Proton Therapy Center and an attorney with 20+ years of legal and management experience in several different industries.
This person is not in the org chart
This person is not in any offices
Kurome Therapeutics
Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.